Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TFXS in Stroke-Associated Pneumonia
NCT04275219Phase 4Unknown
- Sponsor
- Guangzhou University of Chinese Medicine
- Start
- Mar 2019
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Tongfu Xingshen Ye in pneumonia (2 arms), sponsored by Guangzhou University of Chinese Medicine. Primary endpoints: All-cause mortality rate at 90 days and Mortality of stroke associated pneumonia at 90 days. Status: unknown.
02
Drugs
Tongfu Xingshen Ye
03
Conditions
pneumonia
Beyond the preview
Go deeper on NCT04275219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04275219.